Advertisement
Elanco Animal Health Closes Sale Of Aqua Business To Merck Animal Health
RTTNews
|
289 dias atrás

(RTTNews) - Elanco Animal Health, Inc. (ELAN) announced Tuesday it has completed the divestiture of its aqua business to Merck Animal Health (MRK) for approximately $1.3 billion in cash, with approximately $1.05 billion to $1.1 billion in net proceeds available for debt paydown in the third quarter of 2024.
The successful completion of this transaction enables the company to pay down term loan debt on a pro-rata basis per the terms of the company's credit agreements.
Combined with the expected $280 million to $320 million of cash generated from the base business, the company expects to pay down approximately $1.3 billion to $1.4 billion of debt in 2024.
read more
Elanco Animal Health Boosts FY23 Adj. EPS, Revenue Outlook As Q3 Results Top Estimates
Elanco Animal Health Inc. (ELAN) reported Tuesday a net loss for the third quarter of $1.10 billion or $2.22 per share, sharply wider than $65.0 million or $0.13 per share in the prior-year quarter.
RTTNews
|
535 dias atrás
Elanco's Canine Parvovirus Treatment Gets USDA License
Elanco Animal Health Inc. announced that the U.S. Department of Agriculture or USDA has issued a conditional license for its Canine Parvovirus Monoclonal Antibody. The company expects to begin shipping Canine Parvovirus Monoclonal Antibody in the coming weeks, pending individual state approvals. The targeted single-dose monoclonal antibody is the first and only approved targeted therapeutic...
RTTNews
|
723 dias atrás
FDA Approves First Drug For Anemia In Cats With CKD
The U.S. Food and Drug Administration conditionally approved Elanco US Inc.'s Varenzin-CA1 (molidustat oral suspension) for treating anemia in cats with chronic kidney disease or CKD. It is the first drug for the control of nonregenerative anemia associated with CKD in cats. Varenzin-CA1 works by helping to increase production of erythropoietin in the kidney, which in turn stimulates the bone mar
RTTNews
|
724 dias atrás
Commodity Currencies Rise Amid Risk-on Mood
The commodity currencies such as Australia, the New Zealand and the Canadian dollars strengthened against other major currencies in the Asian session on Friday, as traders remain optimistic about a favorable outcome from the ongoing tariff negotiations between the U.S. and several partner countries, particularly China, Japan, South Korea and India. Comments from two U.S. Fed officials about cutting interest rates also improved market sentiment.
RTTNews
|
15 minutos atrás
Canadian Dollar Climbs Against Most Majors
The Canadian dollar strengthened against most major currencies in the Asian session on Friday.
RTTNews
|
38 minutos atrás
NZ Dollar Advances Against Most Majors
The New Zealand dollar strengthened against other major currencies in the Asian session on Friday.
RTTNews
|
45 minutos atrás
Australian Dollar Rises Against Majors
The Australian dollar strengthened against other major currencies in the Asian session on Friday.
RTTNews
|
51 minutos atrás
UK Auto Production Surges On Foreign Demand
UK auto production logged a double-digit growth in March but the expansion was not sufficient to offset the first quarter decline, the Society of Motor Manufacturers and Traders, or SMMT, said Friday. Production of cars and commercial vehicles advanced 17.1 percent year-on-year in March. Production for home market climbed 4.7 percent and that for foreign market surged 23.4 percent.
RTTNews
|
1 h 30 min atrás